Antiseptische Sanierung von Staphylococcus aureus — Keimträgern in der Nase

  • V. Hingst
  • W. Vergetis


Staphylococcus aureus — ein Problemkeim: S. aureus-bedingte Infektionen stellen auch heute noch ein ungelöstes Morbiditätsproblem dar.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aeilts GD, Sapico FL, Canawati HN, Malik GM, Montgomerie JZ (1982) Methicillinresistant-Staphylococcus aureus colonization and infection in a rehabilitation facility. J Clin Microbiol 16: 218–223PubMedGoogle Scholar
  2. Al-Masaudi SB, Russel AD, Day MJ (1988) Activity of mupirocin against Staphylococcus aureus and outer membrane mutants of gram-negative bacteria. Lett Appl Microbiol 7: 45–47CrossRefGoogle Scholar
  3. Barrett SP (1990) The value of nasal mupirocin in containing an outbreak of methicillin- resistant Staphylococcùs aureus in an orthopaedic unit. J Hosp Infect 15: 137–142PubMedCrossRefGoogle Scholar
  4. Boelert JR, DeSmedt RA, Debaere YA, Godart CA, Matthys EG, Schurgers ML, Daneels RF, Gordts BZ, Van Landuyt HW (1989) The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in hemodialysis patients. Nephrol Dial Transplant 4: 278–281Google Scholar
  5. Bommer J, Vergetis W, Hingst V, Lenz W (1991) Elimination of Staphylococcus aureus in dialysis patients by pseudomonic acid nasal ointment. Am Soc Nephrol NY 17.11. 20. 11. 1991Google Scholar
  6. Bradley JR, Evans DB, Calne RY (1987) Long-term survival in hemodialysis patients. Lancet 1: 295–296PubMedCrossRefGoogle Scholar
  7. Bryan CS, Wilson RS, Meade P, Sill LG (1980) Topical antibiotic ointments for staphylococcal nasal carriers: survey of current practices and comparison of bacitracin and vancomycin ointments. Infect Control 1: 153–156PubMedGoogle Scholar
  8. Capobianco JO, Doran CC, Goldman RC (1989) Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob Agents Chemother 33: 156–163PubMedGoogle Scholar
  9. Casewell MW, Hill RLR (1986) Elimination of nasal carriage of Staphylococcus aureus with mupirocin (“pseudomonic acid”) — a controlled trial. J Antimicrob Chemother 17: 365–372PubMedCrossRefGoogle Scholar
  10. Chow JW, Yu VL (1989) Staphylococcus aureus nasal carriage in hemodialysis patients; its role in infection and approaches to prophylaxis. Arch Intern med 149: 1258–1262PubMedCrossRefGoogle Scholar
  11. Cookson BD, Lacey RW, Noble NC, Reeves DS, Wise R, Redhead RJ (1990) Mupirocin-resistant Staphylococcus aureus [letter]. Lancet 335: 1095–1096PubMedCrossRefGoogle Scholar
  12. Coovadia YM, Bhama RH, Johnson AP, Haffejee I, Marples R (1989) A laboratory-confirmed outbreak of rifampin-methicillin-resistant Staphylococcus aureus ( RMRSA) in a newborn nursery. J Hosp Infect 14: 303–312PubMedCrossRefGoogle Scholar
  13. Darouiche R, Perkins B, Musher D, Hamill R, Tsai S (1990) Levels of rifampin and ciprofloxacin nasal secretions: correlation with MIC 90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis 162: 1124–1127PubMedCrossRefGoogle Scholar
  14. Duckworth GJ, Lothian JLE, Williams JD (1988) Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital. J Hosp Infect 11: 1–15PubMedCrossRefGoogle Scholar
  15. Evans LH, Townsend DE (1986) Mupirocin activity against methicillin-resistant Staphylo-coccus aureus [letter]. Med J Austr 145: 55–56Google Scholar
  16. Goldblum SE, Reed WP, Ulrich JA, Goldman RS (1978) Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 7: 1140–1148Google Scholar
  17. Goldblum SE, Ulrich JA, Goldman RS, Reed WP (1982) Nasal and cutaneous Staphylococcus among patients receiving hemodialysis and attending personnel. J Infect Dis 145: 396PubMedCrossRefGoogle Scholar
  18. Goldfarb J, Crenshaw D, O’Horo J, Lemon E, Blumer JL (1988) Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo. Antimicrob Agents Chemother 32: 1780–1783PubMedGoogle Scholar
  19. Gould JC (1955) The effect of local antibiotic on nasal carriage of Staphylococcus pyogenes. J Hyg 53: 379–385CrossRefGoogle Scholar
  20. Hemming VG, Overall JC, Britt MR (1976) Nosocomial infections in a newborn intensive-care unit. N Engl J Med 294: 1310–1316PubMedCrossRefGoogle Scholar
  21. Hill RLR, Duckworth GJ, Casewell MW (1988) Elimination of nasal carriage of methicillinresistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 22: 377–384PubMedCrossRefGoogle Scholar
  22. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG (1988) Prospective study of microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients. J Clin Microbiol 26: 1257–1262PubMedGoogle Scholar
  23. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG (1988) A prospective study of infection in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 9: 534–541PubMedCrossRefGoogle Scholar
  24. Kirmani N, Tuazon CU, Murray HW, Parrish AE, Sheagren JN (1978) Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 138: 1657–1659PubMedCrossRefGoogle Scholar
  25. Lipsky BA, Pecoraro RE, Hanley ME (1988) Immediate and long-term efficacy of ofloxacin and other antibiotics for eradication of Staphylococcus aureus nasal colonization. In: International Congress for Infectious Diseases, Rio de Janeiro, April 17–21, 1988. New York, NY: International Society for Infectious Diseases. 1988:105. AbstractGoogle Scholar
  26. Luzar MA, Coles GA, Faller B, Slingeneyer A, Dah GD, Briat C, Wone C, Knefati Y, Kessler M, Peluso F (1990) Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 322: 505–509PubMedCrossRefGoogle Scholar
  27. Martin RR, White A (1968) The reacquisition of staphylococci by treated carriers: a demonstration of bacterial interference. J Lab Clin Med 71: 791–797PubMedGoogle Scholar
  28. McAnnally TP, Lewis MR, Brown DR (1984) Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother 25: 422–426Google Scholar
  29. Miles AA, Williams RE, Clayton-Cooper B (1944) The carriage of Staphylococcus (pyogenes) aureus in a man and its relation to wound infection. J Pathol Bacteriol 56: 513–524CrossRefGoogle Scholar
  30. Moss B, Squire JR, Topley E, Johnston CM (1948) Nose and skin carriage of Staphylococcus aureus in patients receiving penicillin. Lancet 1: 320–325PubMedCrossRefGoogle Scholar
  31. Mulligan ME, Ruane PJ, Johnston L, Wong P, Wheelock JP, MacDonald K, Reinhardt JF, Johnson CC, Statner B, Blomquist I, McCarthy J, O’Brien W, Gardner S, Hammer L, Citron DM (1987) Ciprofloxazin for eradication of methicillin-resistant Staphylococcus aureus colonization. Am J Med 82: 215–219PubMedGoogle Scholar
  32. Nakashima AK, Allen JR, Martone WJ, Plikaytis BD, Storer B, Cook LM, Wright SP (1984) Epidemic bullous impetigo in a nursery due to a nasal carrier of S. aureus: role of epidemiology and control measures. Infect Control 5: 326–331PubMedGoogle Scholar
  33. Pignatari A, Pfaller M, Hollis R, Sesso R, Leine I, Herwaldt L (1990) Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 28:1898 —1902PubMedGoogle Scholar
  34. Rahman M, Noble WC, Cookson B (1989) Mupirocin-resistant Staphylococcus aureus [letter]. Lancet 2: 387–388Google Scholar
  35. Rahman M, Noble WC, Cookson B (1989) Transmissible mupirocin resistance in Staphylococcus aureus. Epidem Infect 102: 261–270CrossRefGoogle Scholar
  36. Rao N, Jakobs S, Joyce L (1988) Cost-effective eradication of an outbreak of methicillinresistant Staphylococcus aureus in a community teaching hospital. Infect Control Hosp Epidemiol 9: 255–260PubMedCrossRefGoogle Scholar
  37. Raviglione MC, Mariuz P, Pablos-Mendez A, Battan R, Ottuso P, Taranta A (1990) High Staphylococcus aureus nasal carriage in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am J Infect Control 18: 64–69PubMedCrossRefGoogle Scholar
  38. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis J, Wenzel RP (1991) Elimination of coincident Staphyloccus aureus nasal an hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114: 101–106PubMedGoogle Scholar
  39. Rode H, Hanslo D, DeWet PM, Millar AJW, Cywes S (1989) Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection. Antimicrob Agents Chemother. 33: 1358–1361PubMedGoogle Scholar
  40. Schäfer V, Shah PM, Stille W (1990) Symposium „Infektionen durch Staphylokokken“, Frankfurt, 16. 2. 1990Google Scholar
  41. Sesso R, Draibe S, Castelo A, Lerne I, Barbosa D, Ramos O (1989) Staphylococcus aureus skin carriage and development of peritonitis in patients on continous ambulatory peritoneal dialysis. Clin Nephrol 31: 264–268PubMedGoogle Scholar
  42. Sewell CM, Clarridge J, Lacke C, Weinmann EJ, Young EJ (1982) Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 248: 1493–1495PubMedCrossRefGoogle Scholar
  43. Sheagren JN (1984) Staphylococcus aureus — The persistent pathogen (first of two parts). N Engl J Med 310: 1368–1373PubMedCrossRefGoogle Scholar
  44. Sheagren JN (1984) Staphylococcus aureus — The persistent pathogen (second of two parts). N Engl J Med 310: 1437–1442PubMedCrossRefGoogle Scholar
  45. Smith JA, O’Connor JJ, Willis AT (1966) Nasal carriage of Staphylococcus aureus in diabetes mellitus. Lancet 2: 776–777PubMedCrossRefGoogle Scholar
  46. Smith MD, Sanghrajka M, Lock S (1987) Mupirocin-resistant Staphylococcus aureus. Lancet 2: 1472–1473Google Scholar
  47. Smith SM, Eng RHK, Tecson-Tumang F (1989) Ciprofloxazin therapy for methicillinresistant Staphylococcus aureus infections or colonizations. Antimicrob Agents Chemother 33: 181–184PubMedGoogle Scholar
  48. Thornsberry C, Hill BC, Swenson JM, McDougal MK (1983) Rifampin: spectrum of antibacterial activity. Rev Infect Dis 5 (suppl 3): S 412 - S 417CrossRefGoogle Scholar
  49. Tuazon CU, Sheagren JN (1974) Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 129: 725–727PubMedCrossRefGoogle Scholar
  50. Weinstein HJ (1959) The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med 260: 1303–1308PubMedCrossRefGoogle Scholar
  51. Weinstein HJ (1959) Control of nasal-staphylococcal-carrier states. N Engl J Med 260: 1308–1310PubMedCrossRefGoogle Scholar
  52. Wheat U, Kohler RB, White AL, White A (1981) Effect of rifampin on nasal carriers of coagulase-positive staphylococci. J Infect Dis 144: 177PubMedCrossRefGoogle Scholar
  53. Wheat U, Kohler RB, White A (1984) Prevention of infections of skin and skin structures. Am J Med 52: 187–190CrossRefGoogle Scholar
  54. White A, Hemmerly T, Martin MP, Knight V (1959) Studies on the origin of drug-resistant staphylococci in a mental hospital. Am J Med 27: 26–39PubMedCrossRefGoogle Scholar
  55. White A (1964) The use of gentamicin as a nasal ointment. Am J Med Sci 248: 52–55PubMedCrossRefGoogle Scholar
  56. Williams JD, Waltho CA, Ayliffe GAJ, Lowburry GJL (1967) Trials of five antibacterial creams in the control o nasal carriage of Staphylococcus aureus. Lancet 2: 390–392PubMedCrossRefGoogle Scholar
  57. Williams REO (1963) Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 27: 56–71PubMedGoogle Scholar
  58. Wilson SZ, Martin RR, Putman M, Greenberg SB, Wallace RJ Jr, Jemsek JG (1979) Quantitative nasal cultures from carriers of Staphylococcus aureus: effects of the oral therapy with erythromycin, rosamicin, and placebo. Antimicrob Agents Chemother 15: 379–383PubMedGoogle Scholar
  59. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ (1986) Staphylococcus aureus nasal carriage and infections in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 315: 91–96PubMedCrossRefGoogle Scholar
  60. Ziert CH (1982) Long-term Staphylococcus aureus carrier state in hospital patients. J Clin Microbiol 16: 517–520Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • V. Hingst
  • W. Vergetis

There are no affiliations available

Personalised recommendations